Clinical Trials Directory

Trials / Sponsors / Beam Therapeutics Inc.

Beam Therapeutics Inc.

Industry · 6 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Long-term Follow-up Study in Patients Who Received BEAM-101
Hemoglobinopathy, Sickle Cell Disease
—2025-12-15
RecruitingThis is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (
Healthy Subjects, Healthy Participant Study
Phase 12025-10-27
RecruitingA Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen
Glycogen Storage Disease Type Ia
Phase 1 / Phase 22024-12-06
RecruitingA Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency
Alpha 1-Antitrypsin Deficiency
Phase 1 / Phase 22024-06-19
Active Not RecruitingA Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leuke
Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
Phase 1 / Phase 22023-05-25
Active Not RecruitingBEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
Sickle Cell Disease
Phase 1 / Phase 22022-08-30